鲁米诺球菌和前列腺癌:肠-前列腺轴上的新治疗机会
Yutong Liu1, Yilin Wang1, Guojun Wu2
1Xiangya Medical College, Central South University, Changsha, China.
Medical oncology (Northwood, London, England)
|July 28, 2025
概括
肠道细菌Ruminococcus通过其代谢物影响前列腺癌的发展和治疗. 向Ruminococcus为割抵抗性前列腺癌的精密瘤学提供了新的策略.
科学领域:
- 微生物学 微生物学
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 鲁米诺科克 (Ruminococcus) 是一种关键的肠道微生物,在疾病中起着复杂的作用.
- 前列腺癌,特别是抵抗割的前列腺癌 (CRPC),带来了重大的治疗挑战.
研究的目的:
- 审查Ruminococcus在前列腺癌发病和治疗中的双重作用.
- 通过其代谢物和对治疗策略的影响来探索Ruminococcus对CRPC的影响.
主要方法:
- 文献综述侧重于Ruminococcus在肠-前列腺轴内的代谢活动和相互作用.
- 分析Ruminococcus对雄激素受体信号传递,免疫检查点和特定通路的影响.
主要成果:
- 鲁米诺科克通过代谢雄激素和分泌短链脂肪酸 (SCFA) 来调节前列腺癌.
- 它影响免疫检查点,并可以重新激活受体信号后受体剥夺疗法 (ADT).
- 存在菌株特异性影响,R. gnavus与糟糕的结果和R.扭矩相关,改善了CAR-T治疗.
结论:
- 鲁米诺菌对前列腺癌的进展和治疗反应产生重大影响.
- 通过饮食或微生物群调节,准肠-前列腺轴为CRPC提供了新的治疗途径.
- 了解Ruminococcus的机制可以促进前列腺癌管理的精确瘤学.
相关概念视频
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
599
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
599
What is Monogastric Digestion?
72.5K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
72.5K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


